Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers – A real-life prospective study

Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers – A real-life prospective study

Background: Clinical studies on the effectiveness of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma are scarce in China. Moreover, identifying potential biomarkers predicting its efficacy remains a great challenge. Methods: In this prospec...

Full description

Bibliographic Details
Main Authors: Ming Zheng, MD, PhD, Yutong Sima, MD, Chengyao Liu, MD, PhD, Jinming Zhao, MD, Shan Shao, MD, Xinmao Wang, MD, Yue Wang, MD, Feifei Cao, BS, Wei Xiong, BS, Xiangdong Wang, MD, PhD, Luo Zhang, MD, PhD
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:World Allergy Organization Journal
Subjects:
Chronic rhinosinusitis with nasal polyps
Asthma
Omalizumab
Difficult-to-treat
Receiver operating characteristic curves
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455122000783

Internet

http://www.sciencedirect.com/science/article/pii/S1939455122000783

Similar Items